[go: up one dir, main page]

AR132411A1 - CDK2 INHIBITORS - Google Patents

CDK2 INHIBITORS

Info

Publication number
AR132411A1
AR132411A1 ARP240100924A ARP240100924A AR132411A1 AR 132411 A1 AR132411 A1 AR 132411A1 AR P240100924 A ARP240100924 A AR P240100924A AR P240100924 A ARP240100924 A AR P240100924A AR 132411 A1 AR132411 A1 AR 132411A1
Authority
AR
Argentina
Prior art keywords
cdk2 inhibitors
cdk2
inhibitors
cancer
treating
Prior art date
Application number
ARP240100924A
Other languages
Spanish (es)
Inventor
Jr Neil Bifulco
Natasja Brooijmans
Cheng Fang
Joseph L Kim
Emanuele Perola
Philip D Ramsden
Richard Vargas
Steven Mark Wenglowsky
Original Assignee
Blueprint Medicines Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blueprint Medicines Corp filed Critical Blueprint Medicines Corp
Publication of AR132411A1 publication Critical patent/AR132411A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

En la presente descripción se proporciona un compuesto representado por la fórmula (1) estructural, o una sal farmacéuticamente aceptable de este útil para tratar un cáncer.Provided in the present description is a compound represented by structural formula (1), or a pharmaceutically acceptable salt thereof useful for treating a cancer.

ARP240100924A 2020-03-13 2024-04-12 CDK2 INHIBITORS AR132411A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063564604P 2020-03-13 2020-03-13
US202063591862P 2020-10-20 2020-10-20
US202363496146P 2023-04-14 2023-04-14

Publications (1)

Publication Number Publication Date
AR132411A1 true AR132411A1 (en) 2025-06-25

Family

ID=96172436

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP240100924A AR132411A1 (en) 2020-03-13 2024-04-12 CDK2 INHIBITORS

Country Status (1)

Country Link
AR (1) AR132411A1 (en)

Similar Documents

Publication Publication Date Title
UY39832A (en) CDK2 INHIBITORS
CO2022010317A2 (en) egfr inhibitors
CO2021016504A2 (en) cdk inhibitors
CO2024000221A2 (en) Substituted pyrimidinyl-pyrazoles as cdk2 inhibitors
CO2021008681A2 (en) 15-pgdh inhibitor
AR106237A2 (en) HETEROCYCLIC INHIBITORS OF ASPARTIL PROTEASA, ITS PHARMACEUTICALLY ACCEPTABLE SALTS
MX2024002538A (en) Use of ezh2 inhibitor in preparation of drug for treating t-cell lymphoma.
MX2024009926A (en) Compositions and methods for treating cns disorders.
UY40220A (en) EGFR INHIBITORS
AR116951A1 (en) CRYSTALLINE SALTS FROM A PLASMA CALICREIN INHIBITOR
AR126196A1 (en) PROCESS TO PREPARE EGFR INHIBITORS
CO2025016753A2 (en) gsk3α inhibitors and methods of their use
AR132411A1 (en) CDK2 INHIBITORS
DOP2025000090A (en) Cancer treatment methods using isoquinoline or 6-azaquinoline derivatives
UY39662A (en) EGFR INHIBITORS
AR131842A1 (en) METHODS FOR TREATING GLIOMAS
AR129959A1 (en) METHOD FOR TREATING DISEASES OR ORGANIC DISORDERS WITH ASK1 INHIBITORS
CL2025001435A1 (en) DDR1 inhibitor compounds for treating cancer.
AR057403A1 (en) 4- ANILINO-3-QUINOLINCARBONITRILOS FOR THE TREATMENT OF CANCER
MX2025009866A (en) METHODS OF USING FACTOR B INHIBITORS
AR128894A1 (en) KRAS INHIBITORS
MX2025007253A (en) Methods of treating gastrointestinal stromal tumors with ripretinib
CO2022010019A2 (en) Ixabepilone Compositions
AR126823A1 (en) ARYLSULPHONYL (HYDROXY) PIPERIDINES AS CCR6 INHIBITORS